
A promising autologous-cell-based therapy has been developed to address osteoarthritis (OA) by targeting the synovial microenvironment. This innovative treatment redirects the pathological processes in the affected joints, facilitating the repair of articular cartilage. With over 500 million people worldwide affected by OA, this therapy holds significant potential as an effective treatment option.
Like
Save
Share